Belgium decided on Wednesday to reserve the use of the AstraZeneca vaccine for people over 55, following in particular the opinion of the European Medicines Agency (EMA) confirming a link with rare cases of blood clots.
Read also: Covid-19: blood clots, a very rare side effect of the AstraZeneca vaccine
“
On the basis of recent scientific advice, the Belgian health ministers have decided to replace (the vaccine) AstraZeneca with other vaccines for people aged 18 to 55;
for people aged 56 and over, all vaccines will continue to be administered,
”indicates a press release from the Belgian health authorities, who are thus following in the footsteps of several other countries.
